Potentially inappropriate medication (PIM) use and severe drug interactions (SDIs) in older adults with cancer

10Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Older adults with cancer frequently have other co-morbidities requiring prescription pharmacotherapy. The objectives of this study were to identify the prevalence of potentially inappropriate medications (PIMs), severe drug interactions (SDIs) and associated risk factors in these patients. Materials and Methods: This twelve-month prospective observation study was conducted at an Irish Hospital. PIMs were identified in older adults (≥65 years) using STOPP and OncPal criteria; potential SDIs using Stockley's interaction checker. Results: We enrolled 186 patients; mean age 72.5(SD5.7) years, 46.2% female, mean co-morbidities 7.5(SD3.4), median medications 7(IQR4–9). Polypharmacy (≥6 medications) and major polypharmacy (≥11 medications) were identified in 60.8% and 17.7% respectively. STOPP PIMs were observed in 73.1%; median 2(IQR1–3). The most common PIM identified was any drug prescribed beyond the recommended duration (46.5%). For each additional prescription, the odds of receiving a STOPP PIM increased by 79.2% (OR 1.792, 95% CI 1.459–2.02). Potential SDIs were identified in 50.5% participants. The most common were beta-blocker/alpha-blocker (6.5%), selective-serotonin re-uptake inhibitor (SSRI)/proton pump inhibitor (PPI) (5.9%) and SSRI/Aspirin (4.8%). For each additional prescription, the odds of an SDI increased by 50.8% (OR 1.508, 95% CI 1.288–1.764). Seventy-seven (41.4%) participants died within six months of enrolment. OncPal PIMs were observed in 81.8% of this cohort, median 2(IQR1–3). The most common OncPal PIM was statin therapy (38%). For each additional prescription, the odds of receiving an OncPal PIM increased by 38.2%, (OR 1.382, 95% CI 1.080–1.767). Conclusions: PIMs and SDIs are common in this population. Comprehensive specialist evaluation of medications by a geriatrician may identify PIMs thereby reducing related adverse outcomes such as SDIs.

References Powered by Scopus

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician

77638Citations
N/AReaders
Get full text

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

66465Citations
N/AReaders
Get full text

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

5654Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Potentially Inappropriate Medication and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study

14Citations
N/AReaders
Get full text

Prescription trends at the end of life in a palliative care unit: observational study

12Citations
N/AReaders
Get full text

They Need Extra Care Now: Using Potentially Inappropriate Medicine in Metastasis Breast Cancer by Older Adults in Iraq and Aftermaths

9Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lavan, A. H., O’Mahony, D., O’Mahony, D., & Gallagher, P. (2021). Potentially inappropriate medication (PIM) use and severe drug interactions (SDIs) in older adults with cancer. Journal of Geriatric Oncology, 12(6), 872–880. https://doi.org/10.1016/j.jgo.2021.02.021

Readers' Seniority

Tooltip

Lecturer / Post doc 4

33%

PhD / Post grad / Masters / Doc 4

33%

Professor / Associate Prof. 3

25%

Researcher 1

8%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 7

44%

Medicine and Dentistry 5

31%

Nursing and Health Professions 3

19%

Chemistry 1

6%

Save time finding and organizing research with Mendeley

Sign up for free